Don’t let UC
stop you from
doing you
This website is intended for U.S. residents 18 years of age or older.
ZEPOSIA is a once-daily pill for UC—not an injection or an infusion.
ZEPOSIA can help people achieve and maintain remission, while reducing symptoms in as early as 2 weeks.*†
*Individual results may vary.
†Reduces symptoms of rectal bleeding and
stool frequency.
ZEPOSIA is different—it's not a biologic, a 5-ASA, or a steroid.
See what makes ZEPOSIA the first and only UC treatment of its kind.‡
See what makes ZEPOSIA
the first and only UC
treatment of its kind.‡
‡ZEPOSIA is the first and only S1P receptor modulator approved for UC.
Hear from real people taking ZEPOSIA and learn how it fits into their daily lives.
Whether you're considering ZEPOSIA or already taking it, ZEPOSIA 360 Support™ offers the latest information, resources, and support for every step of
your treatment.
Those who are eligible for the ZEPOSIA co-pay savings offer may be able to pay as little as $0 per prescription. View co-pay terms & conditions.
There are a few steps to getting started with ZEPOSIA, and some people may not even have to leave their home.§
§
Home visits for initial routine medical tests are not available to people enrolled in Medicare, Medicaid,
or other federal or state healthcare programs, or to people living in Rhode Island.
Home visits for initial routine medical tests are not
available to people enrolled in Medicare, Medicaid,
or other federal or state healthcare programs, or to
people living in Rhode Island.
Collapse
Do not take ZEPOSIA if you:
Talk to your healthcare provider before taking ZEPOSIA if you have any of these conditions or do not know if you have any of these conditions.
ZEPOSIA may cause serious side effects, including:
Call your healthcare provider right away if you have any of these symptoms of an infection during treatment with ZEPOSIA and for 3 months after your last dose of ZEPOSIA:
Your healthcare provider may delay starting or may stop your ZEPOSIA treatment if you have an infection.
Progressive multifocal leukoencephalopathy (PML). ZEPOSIA can increase your risk for PML, which is a rare brain infection that usually leads to death or severe disability. If PML happens, it usually happens in people with weakened immune systems but has happened in people who do not have weakened immune systems. Symptoms of PML get worse over days to weeks. Call your doctor right away if you have any new or worsening symptoms of PML that have lasted several days, including: weakness on one (1) side of your body, changes in your vision, changes in your thinking or memory, confusion, changes in your personality, loss of coordination in your arms or legs, decreased strength, and/or problems with balance.
Call your healthcare provider if you experience the following symptoms of slow heart rate:
Follow directions from your healthcare provider when starting ZEPOSIA and when you miss a dose.
Continue reading for additional possible serious side effects of ZEPOSIA.
Before taking ZEPOSIA, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take or have recently taken, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using ZEPOSIA with other medicines can cause serious side effects. Especially tell your healthcare provider if you take or have taken:
You should not receive live vaccines during treatment with ZEPOSIA, for at least 1 month before taking ZEPOSIA and for 3 months after you stop taking ZEPOSIA. Vaccines may not work as well when given during treatment with ZEPOSIA.
ZEPOSIA can cause serious side effects, including:
The most common side effects of ZEPOSIA can include:
These are not all of the possible side effects of ZEPOSIA. For more information, ask your healthcare provider or pharmacist.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 1-800-FDA-1088.
Multiple Sclerosis (MS): ZEPOSIA® (ozanimod) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Ulcerative Colitis (UC): ZEPOSIA is a prescription medicine used to treat moderately to severely active ulcerative colitis (UC) in adults.
It is not known if ZEPOSIA is safe and effective in children.
Please see full Prescribing Information, including Medication Guide.
Do not take ZEPOSIA if you:
Talk to your healthcare provider before taking ZEPOSIA if you have any of these conditions or do not know if you have any of these conditions.
ZEPOSIA may cause serious side effects, including: